The payment service has secured $17m in total funding and will now seek to expand into new regions.

The company, which is developing treatments for visual deterioration, has now raised $75m in its first two equity rounds, with Novo Ventures co-leading its series B.

Health food supplier NatureBox has now raised $28m in funding, and has secured Softbank as an investor.

Senseg, which is developing technology for touchscreen interfaces, has secured $6m in a series B round supported by NXP.

AdvanDx, which develops treatments to combat hospital infections, has secured $12m in its latest round, which included pharmaceutical company Merck.

Omada, a developer of treatments for diabetes, has now received $28.5m in funds from investors including Kaiser Permanente.

The education provision startup has raised $10m from a group of new and existing investors, and has now secured $21m since it was founded in 2012.

Altia, an Intel-backed developer of panoramic camera technology for video and web collaboration, has now raised $17.2m in total.

The corporate venturing units of Qualcomm and Samsung both participated in a round that lifted Ineda's total funding to $26m.

The biotechnology company, which is developing treatments for respiratory diseases, has completed a $41m round in which Novo, GlaxoSmithKline, Novartis and Roche all participated as returning investors.